Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $9.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 102 | $9.20B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $9.03B | Healthcare | Biotechnology | United States | Nasdaq |
| 104 | $8.97B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 105 | $8.67B | Healthcare | Biotechnology | United States | Nasdaq |
| 106 | $8.60B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 107 | $7.98B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $7.74B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 109 | $7.57B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $7.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $7.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $6.92B | Healthcare | Biotechnology | United States | Nasdaq |
| 113 | $6.82B | Healthcare | Healthcare Providers | United States | NYSE |
| 114 | $6.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 115 | $6.74B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $6.71B | Healthcare | Healthcare Providers | United States | NYSE |
| 117 | $6.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $6.55B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $6.51B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 120 | $6.17B | Healthcare | Biotechnology | United States | Nasdaq |
| 121 | $6.07B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 122 | $6.05B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 123 | $5.98B | Healthcare | Biotechnology | United States | Nasdaq |
| 124 | $5.92B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 125 | $5.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $5.76B | Healthcare | Medical Devices | United States | Nasdaq |
| 127 | $5.74B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 128 | $5.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $5.65B | Healthcare | Biotechnology | United States | Nasdaq |
| 130 | $5.65B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 131 | $5.57B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $5.53B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $5.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 134 | $5.40B | Healthcare | Medical Devices | United States | NYSE |
| 135 | $5.27B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 136 | $5.23B | Healthcare | Biotechnology | United States | Nasdaq |
| 137 | $5.19B | Healthcare | Medical Devices | United States | Nasdaq |
| 138 | $4.98B | Healthcare | Biotechnology | United States | Nasdaq |
| 139 | $4.94B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $4.91B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $4.81B | Healthcare | Medical Devices | United States | NYSE |
| 142 | $4.80B | Healthcare | Pharmaceuticals | United States | NYSE |
| 143 | $4.55B | Healthcare | Biotechnology | United States | Nasdaq |
| 144 | $4.52B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 145 | $4.51B | Healthcare | Healthcare Providers | United States | NYSE |
| 146 | $4.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 147 | $4.34B | Healthcare | Medical Devices | United States | Nasdaq |
| 148 | $4.32B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $4.30B | Healthcare | Medical Devices | United States | NYSE |
| 150 | $4.27B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 151 | $4.25B | Healthcare | Medical Devices | United States | Nasdaq |
| 152 | $4.19B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 153 | $4.10B | Healthcare | Medical Devices | United States | Nasdaq |
| 154 | $4.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $3.90B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 156 | $3.88B | Healthcare | Biotechnology | United States | Nasdaq |
| 157 | $3.87B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 158 | $3.85B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $3.81B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 160 | $3.73B | Healthcare | Medical Devices | United States | Nasdaq |
| 161 | $3.71B | Healthcare | Medical Devices | United States | Nasdaq |
| 162 | $3.69B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $3.67B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 164 | $3.64B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 165 | $3.61B | Healthcare | Pharmaceuticals | United States | NYSE |
| 166 | $3.60B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 167 | $3.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $3.54B | Healthcare | Healthcare Providers | United States | NYSE |
| 169 | $3.54B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $3.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $3.37B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $3.37B | Healthcare | Biotechnology | United States | Nasdaq |
| 173 | $3.35B | Healthcare | Biotechnology | United States | Nasdaq |
| 174 | $3.34B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 175 | $3.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 176 | $3.21B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 177 | $3.18B | Healthcare | Pharmaceuticals | United States | NYSE |
| 178 | $3.10B | Healthcare | Health Services | United States | NYSE |
| 179 | $3.08B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 180 | $3.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 181 | $2.99B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 182 | $2.97B | Healthcare | Medical Devices | United States | Nasdaq |
| 183 | $2.87B | Healthcare | Medical Devices | United States | Nasdaq |
| 184 | $2.82B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 185 | $2.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $2.77B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 187 | $2.77B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 188 | $2.64B | Healthcare | Healthcare Providers | United States | NYSE |
| 189 | $2.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $2.57B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 191 | $2.56B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 192 | $2.54B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 193 | $2.50B | Healthcare | Biotechnology | United States | Nasdaq |
| 194 | $2.49B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $2.47B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 196 | $2.47B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 199 | $2.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $2.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 890 companies. Market capitalization in USD.